ReviewMolecular biology reports2026
Nipah and chandipura viruses: Emerging neurotropic zoonotic viruses in south asia - a comparative review.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A risk-gate mechanistic-ecological framework for assessing emergence potential of henipa-related viruses.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nipah virus (NiV) and Chandipura virus (CHPV) are emerging zoonotic pathogens in South Asia that pose significant public health threats due to their high morbidity and mortality. NiV, a Henipavirus, is transmitted from fruit bats and pigs to humans and can spread via human-to-human contact, causing severe respiratory and neurological disease. CHPV, a Vesiculovirus, is a leading cause of rapidly progressive encephalitis in rural India and has re-emerged in Africa and Sri Lanka. Despite their shared neurotropic nature, these viruses differ in transmission dynamics, clinical presentation, and virology, complicating diagnosis and control. This review compares the epidemiology, pathogenesis, virology, diagnostic methods, and current therapeutic strategies for NiV and CHPV. There is an urgent need for effective vaccines, better diagnostics, enhanced surveillance, and the implementation of a One Health approach that includes environmental, animal, and human health systems. Understanding the biology of these viruses and their public health implications is critical in the prevention of future outbreaks.
Indexed as
Identifiers
41557033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.